HomeBTAI • NASDAQ
add
BioXcel Therapeutics Inc
Previous close
$1.26
Day range
$1.18 - $1.28
Year range
$1.17 - $8.08
Market cap
26.13M USD
Avg Volume
2.23M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 256.00K | -30.05% |
Operating expense | 10.51M | 5.11% |
Net income | — | — |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 28.42M | -4.82% |
Total assets | — | — |
Total liabilities | 140.38M | 6.80% |
Total equity | — | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | — | — |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | 5.65M | 32.06% |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2017
Headquarters
Website
Employees
37
